Squarepoint’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $806K | Buy |
141,978
+104,037
| +274% | +$591K | ﹤0.01% | 1645 |
|
2025
Q1 | $181K | Buy |
37,941
+25,913
| +215% | +$123K | ﹤0.01% | 2393 |
|
2024
Q4 | $67K | Buy |
+12,028
| New | +$67K | ﹤0.01% | 2606 |
|
2024
Q2 | – | Sell |
-14,520
| Closed | -$105K | – | 2436 |
|
2024
Q1 | $105K | Buy |
14,520
+4,520
| +45% | +$32.8K | ﹤0.01% | 2246 |
|
2023
Q4 | $50.1K | Buy |
+10,000
| New | +$50.1K | ﹤0.01% | 2364 |
|
2022
Q3 | – | Sell |
-568
| Closed | -$3K | – | 2024 |
|
2022
Q2 | $3K | Buy |
568
+77
| +16% | +$407 | ﹤0.01% | 2057 |
|
2022
Q1 | $4K | Hold |
491
| – | – | ﹤0.01% | 2161 |
|
2021
Q4 | $4K | Buy |
+491
| New | +$4K | ﹤0.01% | 2497 |
|
2021
Q2 | – | Sell |
-532
| Closed | -$25K | – | 2558 |
|
2021
Q1 | $25K | Sell |
532
-1,949
| -79% | -$91.6K | ﹤0.01% | 2478 |
|
2020
Q4 | $97K | Sell |
2,481
-1,331
| -35% | -$52K | ﹤0.01% | 2348 |
|
2020
Q3 | $97K | Buy |
3,812
+2,920
| +327% | +$74.3K | ﹤0.01% | 2137 |
|
2020
Q2 | $65K | Sell |
892
-88
| -9% | -$6.41K | ﹤0.01% | 1998 |
|
2020
Q1 | $51K | Buy |
+980
| New | +$51K | ﹤0.01% | 1711 |
|
2019
Q3 | – | Sell |
-1,970
| Closed | -$235K | – | 2189 |
|
2019
Q2 | $235K | Buy |
+1,970
| New | +$235K | ﹤0.01% | 1975 |
|
2019
Q1 | – | Sell |
-475
| Closed | -$85K | – | 2049 |
|
2018
Q4 | $85K | Sell |
475
-437
| -48% | -$78.2K | ﹤0.01% | 1797 |
|
2018
Q3 | $292K | Buy |
+912
| New | +$292K | ﹤0.01% | 1548 |
|